An Open, Single-arm, Single-centre,Phase II Clinical Study Evaluating Cadonilimab in Combination With Ramucirumab for the Treatment of Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
Latest Information Update: 17 Apr 2024
At a glance
- Drugs Cadonilimab (Primary) ; Ramucirumab (Primary)
- Indications Carcinoma; Liver cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 11 Apr 2024 Planned primary completion date changed from 1 May 2024 to 1 Jul 2024.
- 16 May 2023 New trial record
- 14 May 2023 Planned initiation date changed to 1 Jun 2023.